Synaptogenix Liabilities And Stockholders Equity from 2010 to 2025

SNPX Stock  USD 2.84  0.06  2.07%   
Synaptogenix Liabilities And Stockholders Equity yearly trend continues to be fairly stable with very little volatility. Liabilities And Stockholders Equity will likely drop to about 28.6 M in 2025. Liabilities And Stockholders Equity is the total of all liabilities and equity in the company, which should equal Synaptogenix's total assets according to the accounting equation. View All Fundamentals
 
Liabilities And Stockholders Equity  
First Reported
2010-12-31
Previous Quarter
35.8 M
Current Value
28.6 M
Quarterly Volatility
8.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Synaptogenix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Synaptogenix's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 1.8 M or Interest Income of 1.8 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.19 or PTB Ratio of 0.14. Synaptogenix financial statements analysis is a perfect complement when working with Synaptogenix Valuation or Volatility modules.
  
Check out the analysis of Synaptogenix Correlation against competitors.
For more information on how to buy Synaptogenix Stock please use our How to Invest in Synaptogenix guide.

Latest Synaptogenix's Liabilities And Stockholders Equity Growth Pattern

Below is the plot of the Liabilities And Stockholders Equity of Synaptogenix over the last few years. It is the total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation. Synaptogenix's Liabilities And Stockholders Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Synaptogenix's overall financial position and show how it may be relating to other accounts over time.
Liabilities And Stockholders Equity10 Years Trend
Slightly volatile
   Liabilities And Stockholders Equity   
6.8M35.5M38.6M31.1M35.8M28.6M426%9%-19%15%-20%100%
       Timeline  

Synaptogenix Liabilities And Stockholders Equity Regression Statistics

Arithmetic Mean22,208,309
Geometric Mean20,526,948
Coefficient Of Variation39.85
Mean Deviation7,320,274
Median17,897,821
Standard Deviation8,850,893
Sample Variance78.3T
Range31.9M
R-Value0.63
Mean Square Error51T
R-Squared0.39
Significance0.01
Slope1,164,826
Total Sum of Squares1175.1T

Synaptogenix Liabilities And Stockholders Equity History

202528.6 M
202435.8 M
202331.1 M
202238.6 M
202135.5 M
20206.8 M

About Synaptogenix Financial Statements

Synaptogenix investors use historical fundamental indicators, such as Synaptogenix's Liabilities And Stockholders Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Synaptogenix. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Liabilities And Stockholders Equity35.8 M28.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Synaptogenix Stock Analysis

When running Synaptogenix's price analysis, check to measure Synaptogenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synaptogenix is operating at the current time. Most of Synaptogenix's value examination focuses on studying past and present price action to predict the probability of Synaptogenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synaptogenix's price. Additionally, you may evaluate how the addition of Synaptogenix to your portfolios can decrease your overall portfolio volatility.